Archives
2'3'-cGAMP (sodium salt): Benchmark STING Agonist for Inn...
2'3'-cGAMP (sodium salt): Benchmark STING Agonist for Innate Immunity Research
Executive Summary: 2'3'-cGAMP (sodium salt) is the endogenous second messenger produced by cGAS in response to cytosolic double-stranded DNA, binding the STING protein with high affinity (Kd = 3.79 nM) to trigger type I interferon induction (An et al., 2024). This sodium salt form is highly water-soluble (≥7.56 mg/mL), chemically stable at -20°C, and widely used as a benchmark agonist in immunology, cancer, and antiviral research (APExBIO). Tumor microenvironments exploit ENPP1-mediated hydrolysis of extracellular 2'3'-cGAMP to evade immune surveillance (An et al., 2024). The compound's specificity and performance are essential for reliable screening of STING-targeted compounds. This article details the molecular rationale, mechanism, evidence, caveats, and integration parameters based on peer-reviewed and product-supplied data.
Biological Rationale
2'3'-cGAMP is a cyclic dinucleotide produced by cyclic GMP-AMP synthase (cGAS) in response to the presence of cytosolic double-stranded DNA (dsDNA) (An et al., 2024). This process is a pivotal component of the cGAS-STING signaling pathway, a central axis of the innate immune response in mammals. The rapid synthesis of 2'3'-cGAMP triggers STING activation, leading to the induction of type I interferons, particularly IFN-β. These interferons are key mediators in antiviral defense, cancer immunosurveillance, and inflammation regulation. The export of 2'3'-cGAMP enables paracrine activation of bystander cells, amplifying immune responses (An et al., 2024). Tumors, however, can express ENPP1 to degrade extracellular 2'3'-cGAMP, dampening the host immune attack. Thus, exogenous 2'3'-cGAMP (sodium salt) is critical for probing, reconstituting, and manipulating this pathway in controlled experimental systems.
Mechanism of Action of 2'3'-cGAMP (sodium salt)
Upon cytosolic dsDNA detection, cGAS catalyzes the formation of 2'3'-cGAMP from ATP and GTP (An et al., 2024, Fig. 1). 2'3'-cGAMP directly binds to the STING protein located on the endoplasmic reticulum membrane, with a dissociation constant (Kd) of 3.79 nM, indicating high affinity (APExBIO). This binding induces a conformational change in STING, leading to its translocation and subsequent recruitment of TANK-binding kinase 1 (TBK1). TBK1 phosphorylates interferon regulatory factor 3 (IRF3), which then translocates to the nucleus to activate IFN-β gene expression. Exogenously supplied 2'3'-cGAMP (sodium salt) can bypass upstream cGAS activity, directly engaging STING and recapitulating downstream signaling. The molecule's hydrophilicity allows efficient solubility in aqueous buffers, facilitating controlled dosing in cell-based and in vivo assays. ENPP1, an ectonucleotide pyrophosphatase, can hydrolyze extracellular 2'3'-cGAMP, impeding STING pathway activation in the tumor microenvironment (An et al., 2024).
Evidence & Benchmarks
- cGAS synthesizes 2'3'-cGAMP in response to cytosolic dsDNA, initiating the canonical cGAS-STING signaling cascade (An et al., 2024, DOI).
- 2'3'-cGAMP (sodium salt) binds mammalian STING with a Kd of 3.79 nM, showing superior affinity relative to other cyclic dinucleotides (APExBIO).
- Extracellular 2'3'-cGAMP can be degraded by ENPP1, resulting in immune evasion by tumor cells (An et al., 2024, DOI).
- 2'3'-cGAMP functions as a paracrine immunotransmitter via transporters and peptide complexes, amplifying innate immune signaling (An et al., 2024, DOI).
- Inhibitors targeting ENPP1 restore extracellular cGAMP and potentiate antitumor immunity in preclinical models (An et al., 2024, DOI).
- 2'3'-cGAMP (sodium salt) is water-soluble at ≥7.56 mg/mL, chemically defined (C20H22N10Na2O13P2), and stable at -20°C (APExBIO).
Applications, Limits & Misconceptions
2'3'-cGAMP (sodium salt) is indispensable for:
- Innate immune pathway dissection: Used to activate STING directly in cell culture and animal models.
- Immunotherapy research: Screens for STING agonists/antagonists and elucidates tumor immune evasion mechanisms.
- Cancer and antiviral studies: Models type I interferon responses and tumor microenvironment interactions.
- Translational immunology: Evaluates host-pathogen and host-tumor interface using precise pathway activation.
This article extends the mechanistic focus of 2'3'-cGAMP (sodium salt): A Benchmark STING Agonist for I... by integrating the latest insights on ENPP1-mediated immune evasion and direct workflow parameters for translational studies.
For a detailed discussion of neuroinflammatory applications and experimental nuances, see 2'3'-cGAMP (sodium salt): Unlocking cGAS-STING Pathway in.... Here, we clarify the broader relevance for cancer and antiviral immunity.
Common Pitfalls or Misconceptions
- Not a universal STING agonist: 2'3'-cGAMP is most potent in mammalian systems; non-mammalian STING orthologs may not respond equivalently (An et al., 2024).
- ENPP1-mediated hydrolysis: High ENPP1 expression in the tumor microenvironment or extracellular space can degrade exogenous 2'3'-cGAMP, reducing efficacy.
- Solubility caveats: The sodium salt is only soluble in water, not in ethanol or DMSO; improper solvent use can precipitate or inactivate the compound (APExBIO).
- Not an IFN-β inducer in ENPP1-overactive contexts: In systems with high ENPP1, STING activation and subsequent interferon induction may be blunted.
- Not a direct antiviral: 2'3'-cGAMP does not directly inhibit viruses, but activates host defense pathways.
Workflow Integration & Parameters
APExBIO's 2'3'-cGAMP (sodium salt) (SKU: B8362) is supplied as a chemically defined solid. The recommended storage is -20°C, protected from moisture and light, to maintain stability. Prepare working solutions in sterile, deionized water; do not use DMSO or ethanol as solvents. Typical in vitro dosing ranges from 1 nM to 10 μM, depending on cell type and experimental design. For animal studies, dosing regimens should be empirically optimized, starting from published benchmarks. Controls should include vehicle-only and, where appropriate, ENPP1 inhibition (e.g., co-administration of ENPP1 inhibitors) to address extracellular degradation. For screening, use the compound as a positive control to validate pathway responsiveness in reporter assays and cytokine induction panels. See the B8362 kit for full handling and compatibility details. This article updates the protocol-focused discussion in 2'3'-cGAMP (Sodium Salt): Benchmark STING Agonist for Imm... by including ENPP1-related controls and troubleshooting.
Conclusion & Outlook
2'3'-cGAMP (sodium salt) is the reference standard for STING agonist studies due to its molecular fidelity, stability, and robust innate immune activation. Its use has illuminated both the protective and evasive strategies in tumor and viral immunity. ENPP1-mediated hydrolysis presents a challenge for both basic research and translational applications, emphasizing the need for combinatorial approaches. Ongoing clinical and preclinical work targets this axis for next-generation immunotherapies. For comprehensive pathway exploration and drug screening, 2'3'-cGAMP (sodium salt) from APExBIO remains the tool of choice (APExBIO).